Keyphrases
Excessive Bleeding
100%
Thrombocytopenia
68%
Platelet Dense Granules
50%
RUNX1 mutation
50%
Platelet Secretion Defects
50%
Schlafen
50%
96-well
50%
Light Transmission Aggregometry
50%
Bleeding
50%
Dense Granule Secretion
50%
FLI1
50%
High-throughput Screening
50%
Platelet Activation Pathways
50%
Secretion Defect
50%
Platelets
37%
Platelet Function
25%
Runt-related Transcription Factor 1 (RUNX1)
25%
Healthy Volunteers
20%
Inherited Thrombocytopenia
11%
ATP Secretion
11%
Inherited Platelet Defects
10%
Plate-based Assay
10%
Rapid Screening
10%
Collagen
10%
Bleeding Symptoms
10%
Epinephrine
10%
Normal Response
10%
Ristocetin
10%
Antiplatelet Agents
10%
Platelet Defects
10%
96-well Plate
10%
Platelet Activation
10%
Concentration-response Curve
10%
Negative Predictive Value
10%
Screening Assays
10%
Positive Predictive Value
10%
Thrombin Receptor
10%
Arachidonic Acid
10%
Thromboxane
10%
Mild Bleeding Disorders
10%
U46619
10%
Unknown Origin
10%
Friend Leukemia Virus Integration 1
6%
Splicing Alteration
6%
DNA-binding Domain
6%
Platelet Function Disorders
6%
Nonsense
6%
Platelet Agonists
6%
Transcription Factor
6%
Transcriptional Activity
6%
Haploinsufficiency
6%
Heterozygous Missense mutation
5%
Dense Granules
5%
Platelet Formation
5%
Transfected Cells
5%
Binding Region
5%
Unknown Etiology
5%
Lumiaggregometry
5%
Affected Family Members
5%
ATP Binding
5%
Electron Microscopy
5%
Low Platelet Count
5%
Whole Exome Sequencing
5%
ATP Synthase
5%
Inheritance Pattern
5%
Dominant Inheritance
5%
Family Members
5%
Biochemistry, Genetics and Molecular Biology
Platelet
100%
Secretion (Process)
70%
Thrombocytopenia
68%
FLI1
50%
Thrombocyte Release Reaction
50%
RUNX1
50%
Adenosine Triphosphate
30%
Thrombocyte Function
16%
Genotyping
10%
Platelet Count
10%
Thrombopoiesis
10%
Exome Sequencing
10%
Missense Mutation
10%
ATPase
10%
Guanosine Triphosphate
10%
Inheritance
10%
Dominant Inheritance
10%
Electron Microscopy
10%
Fibrinogen
6%
Haploinsufficiency
6%
Transcription Factors
6%
Agonist
6%
DNA-binding Domain
6%
Medicine and Dentistry
Bleeding
50%
High Throughput Screening
50%
Thrombocyte Activation
50%
Volunteer
33%
Thrombocyte Anomaly
33%
Thrombocyte Function
33%
Epinephrine
16%
In Vitro
16%
15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid
16%
Arachidonic Acid
16%
Ristocetin
16%
Concentration Response
16%
Thrombin Receptor Activating Peptide
16%
Antiplatelet Drug
16%
Adenosine Diphosphate
16%
Platelet
16%
Thromboxane
16%
Bleeding Disorder
16%